Ensign Peak Advisors’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,080
Closed -$42K 2345
2022
Q2
$42K Hold
8,080
﹤0.01% 2083
2022
Q1
$56K Hold
8,080
﹤0.01% 2114
2021
Q4
$101K Buy
+8,080
New +$101K ﹤0.01% 2058
2021
Q2
Sell
-17,498
Closed -$758K 1847
2021
Q1
$758K Buy
+17,498
New +$758K ﹤0.01% 1504